Huapont Life Sciences (002004.SZ) has obtained the drug registration certificate for Ibrutinib tablets.
Huabang Health (002004.SZ) announced that its wholly-owned subsidiary, Chongqing Huabang Pharmaceutical Co., Ltd. (hereinafter referred to as "Huabang Pharmaceutical"), recently received the Drug Registration Certificate for Ibrutinib Tablets approved by the National Medical Products Administration. Ibrutinib Tablets were registered as a Class 3 chemical drug, which is considered to have passed the consistency evaluation of quality and efficacy of generic drugs. The official approval of this product will further enrich the company's product pipeline in the field of anti-tumor treatments, while providing clinical patients with more high-quality medication options.
Huapont Life Sciences (002004.SZ) announced that its wholly-owned subsidiary, Chongqing Huabang Pharmaceutical Co., Ltd. (hereinafter referred to as "Huabang Pharmaceutical"), recently received the Drug Registration Certificate for Ibrutinib Tablets issued by the National Medical Products Administration. Ibrutinib Tablets were filed as a Class 3 chemical drug, which is regarded as passing the consistency evaluation of quality and efficacy for generic drugs. The official approval of this product will further enrich the company's product pipeline in the oncology field and provide more high-quality medication options for clinical patients.
Related Articles
HK Stock Market Move | LEGEND HOLDING (03396) rose over 6% following a positive earnings forecast, expecting a net profit attributable to equity holders in the first half to increase by no less than 186% year-on-year.
HK Stock Market Move | XUNCE (03317) surged over 18% as revenue driven by its token business significantly increased,.
HK Stock Market Move | TAI HING GROUP (06811) rose over 8% after announcing a profit alert, expecting a net profit attributable to shareholders of approximately HKD 72 million to HKD 78 million for the first half of the year.
HK Stock Market Move | LEGEND HOLDING (03396) rose over 6% following a positive earnings forecast, expecting a net profit attributable to equity holders in the first half to increase by no less than 186% year-on-year.
HK Stock Market Move | XUNCE (03317) surged over 18% as revenue driven by its token business significantly increased,.
HK Stock Market Move | TAI HING GROUP (06811) rose over 8% after announcing a profit alert, expecting a net profit attributable to shareholders of approximately HKD 72 million to HKD 78 million for the first half of the year.
RECOMMEND
